Skip to main content

Published locations for FDA approves dupilumab for children with eczema aged 6 months to 5 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves dupilumab for children with eczema aged 6 months to 5 years

User login

  • Reset your password
  • /content/fda-approves-dupilumab-children-eczema-aged-6-months-5-years
  • /clinicianreviews/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6
  • /edermatologynews/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6
  • /familypracticenews/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6
  • /pediatricnews/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6-months
  • /pediatrics/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6-months-5
  • /dermatology/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6-months-5
  • /familymedicine/article/255281/atopic-dermatitis/fda-approves-dupilumab-children-eczema-aged-6-months